Abstract 624: MiR-33 Antagonism Prevents the Progression of Atherosclerosis by Promoting an M2 Macrophage Phenotype
Hasini Ediriweera(New York University), Kathryn J. Moore(New York University), Katey J. Rayner(University of Ottawa), Sarah Hamerling, Alessandro G. Salerno(Wake Forest University), Mireille Ouimet(University of Ottawa), Edward A. Fisher(Mount Sinai Hospital), Frederick J. Sheedy(Trinity College Dublin), Susan Hutchison(Bell (Canada)), Christine Esau(Ionis Pharmaceuticals (United States))
Cited by 1
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k